Social Media Impact of the Food and Drug Administration's Drug Safety Communication Messaging About Zolpidem: Mixed-Methods Analysis.

Michael S Sinha Clark C Freifeld John S Brownstein Macarius M Donneyong Paula Rausch Brian M Lappin Esther H Zhou Gerald J Dal Pan Ajinkya M Pawar Thomas J Hwang Jerry Avorn Aaron S Kesselheim

Published in: JMIR public health and surveillance (2018)

Social media offers challenges and opportunities for dissemination of the DSC messages. The FDA could consider strategies for more actively disseminating DSC safety information through social media platforms, particularly when announcements require updating. The FDA may also benefit from directly contributing content to websites like Wikipedia that are frequently accessed for drug-related information.

Keyphrases

social media
health information
drug administration
working memory
drug induced
adverse drug
smoking cessation
emergency department
electronic health record